A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B

被引：0
|
作者：
Hsu, Y. -C. [1 ]
Tanaka, Y. [2 ,3 ]
Nguyen, M. [4 ]
Chang, C. -Y. [1 ]
Tai, C. -M. [5 ]
Tseng, C. -H. [5 ]
Chen, C. -C. [6 ]
Wu, M. -S. [6 ]
Lin, J. -T. [1 ]
机构：
[1] Fu Jen Catholic Univ, Coll Med, New Taipei, Taiwan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan
[3] Liver Unit, Nagoya, Aichi, Japan
[4] Stanford Univ, Med Ctr, Dept Med, Palo Alto, CA 94304 USA
[5] E Da Hosp, Dept Med, Kaohsiung, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
10.1016/S0168-8278(18)31243-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-303
引用
收藏
页码：S498 / S498
页数：1
相关论文
共 50 条
  • [1] Hepatitis B Core-Related Antigen and the Novel Scale-B Score to Predict Relapse Risk after Cessation of Nucleos(t)Ide Analogs in Patients with Chronic Hepatitis B
    Hsu, Yao-Chun
    Nguyen, Mindie H.
    Mou, Lien-Juei
    Wu, Ming-Shiang
    Yang, Tzeng-Huey
    Chen, Chieh-Chang
    Tseng, Cheng-Hao
    Tai, Chi-Ming
    Wu, Chun-Ying
    Lin, Jaw-Town
    Tanaka, Yasuhito
    Chang, Chi-Yang
    HEPATOLOGY, 2018, 68 : 236A - 237A
  • [2] Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk
    Hsu, Yao-Chun
    Nguyen, Mindie H.
    Mo, Lein-Ray
    Wu, Ming-Shiang
    Yang, Tzeng-Huey
    Chen, Chieh-Chang
    Tseng, Cheng-Hao
    Tai, Chi-Ming
    Wu, Chun-Ying
    Lin, Jaw-Town
    Tanaka, Yasuhito
    Chang, Chi-Yang
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (01) : 107 - 115
  • [3] Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B
    Matsumoto, Akihiro
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) : 127 - 128
  • [4] Hepatitis B core-related antigen: a strong indicator for cessation of nucleos(t)ide analog therapy in patients with chronic hepatitis B
    Akihiro Matsumoto
    Journal of Gastroenterology, 2017, 52 : 127 - 128
  • [5] Time-varying Serum Gradient of Hepatitis B Surface Antigen after Cessation of Nucleos(t)ide Analogues and Risk of Off-therapy Relapse
    Hsu, Yao-Chun
    Huang, Yen-Tsung
    Wu, Chun-Ying
    Chang, Chi-Yang
    Mo, Lein-Ray
    Wu, Ming-Shiang
    Kao, Jia-Horng
    Yang, Tzeng-Huey
    Lin, Jaw-Town
    HEPATOLOGY, 2016, 64 : 945A - 945A
  • [6] THE ROLE OF QUANTITATIVE HEPATITIS B SURFACE ANTIGEN, HEPATITIS B CORE-RELATED ANTIGEN AND HEPATITIS B RNA IN PREDICTION OF HEPATITIS B RELAPSE AFTER NUCLEOS(T)IDE ANALOGUE TREATMENT DISCONTINUATION IN CHRONIC HEPATITIS B
    Kaewdech, Apichat
    Sripongpun, Pimsiri
    Jundee, Sawangpong
    Witeerungroj, Teepawit
    Tanaka, Yasuhito
    Tangkijvanich, Pisit
    Piratvisuth, Teerha
    HEPATOLOGY, 2019, 70 : 413A - 414A
  • [7] Combined hepatitis B core-related antigen and surface antigen levels predict hepatocellular carcinoma development in patients treated with nucleos(t)ide analogues
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Kobayashi, Masahiro
    Fujiyama, Shunichiro
    Kunimoto, Hideo
    Sorin, Yushi
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    HEPATOLOGY, 2015, 62 : 1193A - 1194A
  • [8] The development of HCC in chronic hepatitis B patients with nucleos (t)ide analogs: Focus on hepatitis B surface antigen and core-related antigen
    Ozeki, Itaru
    Suii, Hirokazu
    Tatsumi, Ryoji
    Yamaguchi, Masakatsu
    Kimura, Mutsuumi
    Arakawa, Tomohiro
    Nakajima, Tomoaki
    Kuwata, Yasuaki
    Ohmura, Takumi
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E477 - E477
  • [9] Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B
    van Boemmel, Florian
    Verbinnen, Thierry
    Agarwal, Kosh
    Vanwolleghem, Thomas
    Lampertico, Pietro
    Buti, Maria
    Janczewska, Ewa
    Bourliere, Marc
    Jezorwski, John
    Donohue, Kathleen
    Kim, Gloria
    Kakuda, Thomas N.
    De Meyer, Sandra
    Bakala, Adam
    Biermer, Michael
    Lenz, Oliver
    HEPATOLOGY COMMUNICATIONS, 2025, 9 (03)
  • [10] Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
    Liao, Guichan
    Ding, Xia
    Xia, Muye
    Wu, Yin
    Chen, Hongjie
    Fan, Rong
    Zhang, Xiaoyong
    Cai, Shaohang
    Peng, Jie
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 4967 - 4976
12345